AI-Enabled Biologics Data Analysis For All: Interview with baSeq

Mikkel Reincke Fuglsang
CEO & Co-founder
baSeq
Format: 18 Minute Interview
Register free to attend thought leadership
Do you have a question you’d like Mikkel Reincke Fuglsang to answer during the session?
Register and askRelated posts

AI-Enabled Biologics Data Analysis For All: Interview with baSeq
Upcoming events
Engineering the Future of ADCs – Innovation, Efficacy, and Clinical Integration
Online
Join leading voices in oncology and bioconjugation for a 1-hour virtual thought leadership session exploring how tumour biology, real-world data, and chemical innovation are converging to shape the future of Antibody–Drug Conjugates (ADCs).
Biologics US 2025
In-Person
Biologics US 2025 brings together leaders in biologics R&D through two focused programs on one dynamic platform. Over two immersive days, the event spotlights breakthrough innovations in proteins, antibodies, and the development of antibody-drug conjugates (ADCs).
Register for free to view
-
Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.
-
From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.
-
Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.
Already registered? Sign In.